Literature DB >> 26573417

MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C.

Guangyan Li1, Fang Yang1, Shiyu Gu2, Zhenjuan Li1, Minghui Xue3.   

Abstract

Deregulation of microRNAs (miRNAs) is known to be associated with drug resistance in human cancers. However, the precise role of miR‑101 in the cisplatin (DPP) resistance of human gastric cancer cells has not been elucidated, yet. The present study revealed that miR‑101 was markedly downregulated in gastric cancer cell lines compared to that in the normal gastric mucosa epithelial cell line GES1. Furthermore, a significant decrease in miR‑101 levels, accompanied with an increased expression of vascular endothelial growth factor (VEGF)‑C in DDP‑resistant SGC7901 gastric cancer cells (SGC7901/DDP) compared with those in native SGC7901 cells was observed. In addition, forced overexpression of miR‑101 significantly inhibited cell proliferation, while enhancing cisplatin‑induced apoptosis of SGC7901/DDP cells. A luciferase reporter assay confirmed that VEGF‑C was a direct target of miR‑101 in SGC7901/DDP cells. Forced overexpression of miR‑101 in SGC7901/DDP cells reduced the expression of VEGF‑C, while knockdown of miR‑101 expression significantly enhanced VEGF‑C expression in SGC7901/DDP cells. Finally, overexpression of VEGF‑C inhibited DDP‑induced apoptosis in SGC7901 cells. In conclusion, the results of the present study suggested that miR‑101 inhibited the proliferation and promoted DDP‑induced apoptosis of DDP‑resistant gastric cancer cells, at least in part via targeting VEGF-C.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26573417     DOI: 10.3892/mmr.2015.4560

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.

Authors:  Yuu Saitoh; Tomohiro Umezu; Satoshi Imanishi; Michiyo Asano; Seiichiro Yoshizawa; Seiichiro Katagiri; Tamiko Suguro; Hiroaki Fujimoto; Daigo Akahane; Chiaki Kobayashi-Kawana; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

2.  Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Authors:  Hani Choudhry; Mazin A Zamzami; Ziad Omran; Wei Wu; Marc Mousli; Christian Bronner; Mahmoud Alhosin
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

3.  1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.

Authors:  Yingyu Ma; Wei Luo; Brittany L Bunch; Rachel N Pratt; Donald L Trump; Candace S Johnson
Journal:  Oncotarget       Date:  2017-07-27

4.  An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells.

Authors:  Zuwen Zhang; Jumei Zhao; Qiuxia Pang; Aihong Wang; Meini Chen; Xiaoli Wei
Journal:  Mol Med Rep       Date:  2017-06-08       Impact factor: 2.952

5.  Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Yuka I Kawasawa; Milind Mahajan; Niraj J Gusani; Arun J Sanyal; Dino J Ravnic
Journal:  Sci Rep       Date:  2018-05-22       Impact factor: 4.379

6.  Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo.

Authors:  Feng Wei; Xin Jiang; Hao-Yue Gao; Shuo-Hui Gao
Journal:  Int J Oncol       Date:  2017-09-22       Impact factor: 5.650

7.  Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen.

Authors:  Cheng Tang; Xi Cheng; Shan Yu; Yan Wang; Jun Hou; Qian Li; Zhenbin Shen; Tianshu Liu; Yuehong Cui
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

Review 8.  Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs.

Authors:  Bernhard Biersack
Journal:  Noncoding RNA Res       Date:  2016-10-13

9.  Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway.

Authors:  Zongyao Zhang; Xin Yu; Bo Zhou; Jiajia Zhang; Jiacong Chang
Journal:  Biomed Res Int       Date:  2020-08-13       Impact factor: 3.411

Review 10.  Non-coding RNA in drug resistance of gastric cancer.

Authors:  Ya-Jun Luo; Qing-Mei Huang; Yan Ren; Zi-Lin Liu; Cheng-Fei Xu; Hao Wang; Jiang-Wei Xiao
Journal:  World J Gastrointest Oncol       Date:  2019-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.